New hope for kids with tough cancers: scientists test 'Re-Trained' immune cells

NCT ID NCT04483778

Summary

This early-stage study is testing a new type of personalized cell therapy for children and young adults whose solid tumors have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer, and then infuse them back into the patient. The main goals are to find a safe dose, see if the cells can be reliably made, and check for any early signs that the treatment might help shrink tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

Conditions

Explore the condition pages connected to this study.